These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 10319404)
1. [The application of cerebrolysine in ischemic stroke]. Vilenskiĭ BS; Semenova GM; Shirokov EA Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(4):65-9. PubMed ID: 10319404 [No Abstract] [Full Text] [Related]
2. Hope Dies Last-Evidence Again Fails to Support a Neuroprotectant: Cerebrolysin for Acute Ischemic Stroke. Bereczki D Stroke; 2017 Sep; 48(9):2343-2344. PubMed ID: 28747461 [No Abstract] [Full Text] [Related]
3. [Comparative analysis of efficacy of certain neuroprotectors in ischemic stroke]. Skorokhodov AP; Dudina AA; Kolesnikova EA; Koron AE; Kobantsev IuA; Sedova AA Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Suppl 17():52-6. PubMed ID: 18193579 [TBL] [Abstract][Full Text] [Related]
4. Status of neuroprotection for acute ischemic stroke. Mohr JP Neurologia; 1999; 14 Suppl 4():54-6. PubMed ID: 10613034 [No Abstract] [Full Text] [Related]
5. [The experience with endolumbar application of cerebrolysin in hemispheric ischemic stroke]. Vilenskiĭ BS; Odinak MM; Shirokov EA; Vozniuk IA; Semenova GM; Grinevich TV Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(11):31-4. PubMed ID: 11247183 [TBL] [Abstract][Full Text] [Related]
6. [The objective of acute stroke therapy and neuroprotective therapeutic approaches]. Fisher M Rev Neurol; 1999 Sep 16-30; 29(6):536-44. PubMed ID: 10584269 [TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effect of a new taurinamide derivative--Taurepar. Krylova IB; Bulion VV; Gavrovskaya LK; Selina EN; Kuznetzova NN; Sapronov NS Adv Exp Med Biol; 2006; 583():543-50. PubMed ID: 17153643 [No Abstract] [Full Text] [Related]
12. [A progressive view on the treatment and rehabilitation of acute ischemic stroke]. Yanishevskiy SN; Khatkova SE Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(12. Vyp. 2):50-54. PubMed ID: 36582161 [TBL] [Abstract][Full Text] [Related]
13. [The effect of cerebrolysin on the clinical symptoms and the course of ischemic encephalopathy]. Chukanova EI Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(1):42-5. PubMed ID: 15704482 [No Abstract] [Full Text] [Related]
14. Initial experience with remacemide hydrochloride in patients with acute ischemic stroke. Muir KW; Lees KR Ann N Y Acad Sci; 1995 Sep; 765():322-3. PubMed ID: 7486631 [No Abstract] [Full Text] [Related]
15. [An impact of neuroprotective therapy on blood rheological and morphodensitometric parameters in patients with chronic cerebral ischemia]. Anisimova AV; Kolesnikova TI; Iutskova EV; Galkin SS; Zimin IA Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(10):72-80. PubMed ID: 25591521 [TBL] [Abstract][Full Text] [Related]
17. Suramin reduces infarct volume in a model of focal brain ischemia in rats. Kharlamov A; Jones SC; Kim DK Exp Brain Res; 2002 Dec; 147(3):353-9. PubMed ID: 12428143 [TBL] [Abstract][Full Text] [Related]
18. [Clinical and pathogenetical peculiarities and treatment policy in ischemic stroke of elderly and old age]. Gafurov BG; Alikulova NA Zh Nevrol Psikhiatr Im S S Korsakova; 2004; (Suppl 11):44-6. PubMed ID: 15559220 [TBL] [Abstract][Full Text] [Related]
19. [Neurotoxicity, neuroprotection and therapeutic window in cerebral ischemia]. Mostacero E Rev Neurol; 1999 Sep 16-30; 29(6):513-4. PubMed ID: 10584264 [No Abstract] [Full Text] [Related]
20. [Specific aspects of neurodestructive process and neuroprotective therapy for nervous system disorders]. Odinak MM; Kholin AV; Litvinenko IV; Dyskin DE Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(11):64-8. PubMed ID: 11765620 [No Abstract] [Full Text] [Related] [Next] [New Search]